Phase II trial of docetaxel in patients with advanced or metastatic transitional-cell carcinoma.
- 1 May 1997
- journal article
- clinical trial
- Published by American Society of Clinical Oncology (ASCO) in Journal of Clinical Oncology
- Vol. 15 (5) , 1853-1857
- https://doi.org/10.1200/jco.1997.15.5.1853
Abstract
PURPOSEA phase II trial of docetaxel was conducted to assess its efficacy and toxicity in patients with advanced transitional-cell carcinoma (TCC) who had failed to respond to prior cisplatin-based...Keywords
This publication has 0 references indexed in Scilit: